（18）¹⁸F - FDG PET/CT与骨闪烁显像在胃癌随访中的比较
(18)F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer.
作者信息
Sollini M, Calabrese L, Zangheri B, Erba P A, Gramaglia A, Gasparini M
机构信息
Nuclear Medicine Unit, IRCCS MultiMedica, Via Milanese 300, 20099 Sesto San Giovanni (MI), Italy.
Nuclear Medicine Unit, IRCCS MultiMedica, Via Milanese 300, 20099 Sesto San Giovanni (MI), Italy.
出版信息
Rev Esp Med Nucl Imagen Mol. 2016 Mar-Apr;35(2):121-3. doi: 10.1016/j.remn.2015.10.002. Epub 2015 Nov 30.
A 53-year-old patient underwent a positron emission tomography/computed tomography with 2-fluoro-2-deoxy-d-glucose ((18)F-FDG PET/CT) in the suspicious of gastric tumor recurrence (mediastinal and abdominal lymph nodes). PET/CT identified only an area of (18)F-FDGuptake in the twelfth thoracic vertebrae. Unexpectedly, a bone scintigraphy revealed many "hot" spots changing the diagnosis (single metastasis versus plurimetastatic disease) and impacting on patient's management.
一名53岁的患者因怀疑胃肿瘤复发（纵隔和腹部淋巴结）接受了2-氟-2-脱氧-D-葡萄糖正电子发射断层扫描/计算机断层扫描（(18)F-FDG PET/CT）检查。PET/CT仅在第十二胸椎发现一个(18)F-FDG摄取区域。出乎意料的是，骨闪烁显像显示出许多“热点”，改变了诊断结果（单发转移与多发转移疾病），并影响了患者的治疗方案。
Zotero 插件